# Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer

> **NCT02875626** · NA · COMPLETED · sponsor: **Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie** · enrollment: 80 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Infracyanine

## Key facts

- **NCT ID:** NCT02875626
- **Lead sponsor:** Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-02
- **Final completion:** 2019-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02875626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02875626, "Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02875626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*